GR1002034B - Process for the preparation of dry processed particles dry processed particles thus obtained and pharmaceutical compositions containing such particles. - Google Patents

Process for the preparation of dry processed particles dry processed particles thus obtained and pharmaceutical compositions containing such particles.

Info

Publication number
GR1002034B
GR1002034B GR940100215A GR940100215A GR1002034B GR 1002034 B GR1002034 B GR 1002034B GR 940100215 A GR940100215 A GR 940100215A GR 940100215 A GR940100215 A GR 940100215A GR 1002034 B GR1002034 B GR 1002034B
Authority
GR
Greece
Prior art keywords
particles
dry processed
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
GR940100215A
Other languages
Greek (el)
Inventor
Jean-Marc Ruiz
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of GR1002034B publication Critical patent/GR1002034B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
GR940100215A 1993-05-15 1994-04-28 Process for the preparation of dry processed particles dry processed particles thus obtained and pharmaceutical compositions containing such particles. GR1002034B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310030A GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same

Publications (1)

Publication Number Publication Date
GR1002034B true GR1002034B (en) 1995-10-31

Family

ID=10735537

Family Applications (1)

Application Number Title Priority Date Filing Date
GR940100215A GR1002034B (en) 1993-05-15 1994-04-28 Process for the preparation of dry processed particles dry processed particles thus obtained and pharmaceutical compositions containing such particles.

Country Status (34)

Country Link
JP (1) JP3139913B2 (en)
KR (1) KR100341261B1 (en)
CN (1) CN1050534C (en)
AT (1) AT406017B (en)
AU (1) AU685094B2 (en)
BE (1) BE1008323A3 (en)
BR (1) BR9401968A (en)
CA (1) CA2123481C (en)
CH (1) CH688572A5 (en)
DE (1) DE4416812C2 (en)
DK (1) DK171454B1 (en)
DZ (1) DZ1779A1 (en)
ES (1) ES2097083B1 (en)
FI (1) FI112915B (en)
FR (1) FR2705232B1 (en)
GB (2) GB9310030D0 (en)
GR (1) GR1002034B (en)
HU (1) HU220617B1 (en)
IE (1) IE940392A1 (en)
IN (1) IN182330B (en)
IT (1) IT1269508B (en)
LU (1) LU88482A1 (en)
MA (1) MA23194A1 (en)
NL (1) NL9400795A (en)
NO (1) NO307403B1 (en)
NZ (1) NZ260520A (en)
OA (1) OA09939A (en)
PL (1) PL175780B1 (en)
PT (1) PT101518B (en)
RU (1) RU2125869C1 (en)
SE (1) SE519004C2 (en)
SG (1) SG46631A1 (en)
TN (1) TNSN94046A1 (en)
ZA (1) ZA943316B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220137B (en) * 1993-01-06 2001-11-28 Kinerton Ltd. Ionic molecular conjugates of biodegradable polyesters and biologically active polypeptides, a process for their preparation and a method for producing microparticles
DE69435055T2 (en) * 1993-01-06 2008-12-04 IPSEN Manufacturing Ireland Ltd., Blanchardstown Biodegradable polyesters for the preparation of ionic molecular conjugates with bioactive polypeptides
DE19604744A1 (en) 1996-02-09 1997-08-14 Henkel Kgaa Technical di- / triglyceride mixtures
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
DE19617137C1 (en) * 1996-04-29 1997-02-27 Henkel Kgaa Use of branched alcohol ester(s) of olefin-di:carboxylic acid copolymers
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
US6867181B1 (en) 1997-06-02 2005-03-15 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
EP1183014B1 (en) * 1999-06-14 2003-10-08 Cosmo S.p.A. Controlled release and taste masking oral pharmaceutical compositions
CA2427938C (en) 1999-11-15 2010-02-16 Bio Syntech Canada Inc. Novel temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution, composition and preparation thereof
CA2350728A1 (en) * 2000-06-16 2001-12-16 Nippon Shokubai Co., Ltd. Crosslinked polmer, method for manufacturing it and use thereof
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH468192A (en) * 1964-06-19 1969-02-15 Ciba Geigy Process for the manufacture of medicaments in pearl form
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH672887A5 (en) * 1987-10-14 1990-01-15 Debiopharm Sa
WO1989003678A1 (en) * 1987-10-30 1989-05-05 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
DE3916020C2 (en) * 1989-05-17 1994-06-01 Burkhard Dr Wichert Retarding microparticles made from biodegradable polyesters; Process for their preparation without the use of toxic solvents and pharmaceutical preparations containing these microparticles
EP0452145B1 (en) * 1990-04-12 1996-11-13 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Coated composition and its preparation process
JP3116311B2 (en) * 1990-06-13 2000-12-11 エーザイ株式会社 Manufacturing method of microsphere
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
SE9003296L (en) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab PROCEDURE SHOULD FORMULATE MEDICINAL PRODUCTS
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
SE467815B (en) * 1991-05-27 1992-09-21 Bengt Hjalmar Aagerup Med Firm METHOD FOR MAKING REPRODUCABLE PARTICLES OF DEFINED SIZE
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
CA2129514A1 (en) * 1992-03-12 1993-09-16 M. Amin Khan Controlled released acth containing microspheres
SE9200858L (en) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Method for producing delayed release pellets
ES2181691T5 (en) * 1992-06-11 2007-10-01 Alkermes Controlled Therapeutics, Inc. ERYTHROPOYETINE PROTEIN DISTRIBUTION SYSTEM.
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
JP2651320B2 (en) * 1992-07-16 1997-09-10 田辺製薬株式会社 Method for producing sustained-release microsphere preparation
FR2693905B1 (en) * 1992-07-27 1994-09-02 Rhone Merieux Process for the preparation of microspheres for the sustained release of the hormone LHRH and its analogs, microspheres and formulations obtained.
GB2273874A (en) * 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix

Also Published As

Publication number Publication date
CA2123481A1 (en) 1994-11-16
JP3139913B2 (en) 2001-03-05
BR9401968A (en) 1994-12-13
PT101518B (en) 2000-12-29
GB9310030D0 (en) 1993-06-30
ES2097083A1 (en) 1997-03-16
SE9401557D0 (en) 1994-05-05
NO307403B1 (en) 2000-04-03
IT1269508B (en) 1997-04-01
CH688572A5 (en) 1997-11-28
JPH072652A (en) 1995-01-06
HU220617B1 (en) 2002-03-28
DK171454B1 (en) 1996-11-04
LU88482A1 (en) 1994-12-01
ITMI940931A0 (en) 1994-05-11
AT406017B (en) 2000-01-25
PT101518A (en) 1995-03-01
SG46631A1 (en) 1998-02-20
FR2705232A1 (en) 1994-11-25
FR2705232B1 (en) 1995-08-25
CA2123481C (en) 2005-01-11
GB9409565D0 (en) 1994-07-06
IN182330B (en) 1999-03-20
HK1002831A1 (en) 1998-09-18
OA09939A (en) 1994-11-15
IE940392A1 (en) 1994-11-16
ZA943316B (en) 1995-01-16
NO941810L (en) 1994-11-16
ES2097083B1 (en) 1997-12-01
CN1104557A (en) 1995-07-05
FI942222A0 (en) 1994-05-13
PL175780B1 (en) 1999-02-26
DE4416812C2 (en) 2003-02-06
FI112915B (en) 2004-02-13
TNSN94046A1 (en) 1995-04-25
AU685094B2 (en) 1998-01-15
KR100341261B1 (en) 2002-09-27
ITMI940931A1 (en) 1995-11-11
HUT67599A (en) 1995-04-28
NL9400795A (en) 1994-12-01
GB2277915A (en) 1994-11-16
MA23194A1 (en) 1994-12-31
CN1050534C (en) 2000-03-22
DZ1779A1 (en) 2002-02-17
GB2277915B (en) 1997-10-29
SE9401557L (en) 1994-11-16
RU2125869C1 (en) 1999-02-10
DE4416812A1 (en) 1994-11-17
NZ260520A (en) 1994-12-22
BE1008323A3 (en) 1996-04-02
AU6308494A (en) 1994-11-17
ATA98794A (en) 1999-06-15
NO941810D0 (en) 1994-05-13
DK54994A (en) 1994-11-16
HU9401412D0 (en) 1994-08-29
FI942222L (en) 1994-11-16
SE519004C2 (en) 2002-12-17

Similar Documents

Publication Publication Date Title
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IL116211A0 (en) Peptide compounds pharmaceutical compositions containing the same and processes for the preparation thereof
IL106600A (en) Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof
IL115484A0 (en) Polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
PT84936A (en) Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
HU902693D0 (en) Process for the preparation of n-heteroaryl-4-quinolin-amine compounds and pharmaceutical compositions containing them
ZA929883B (en) Pharmaceutical composition and process for the preparation thereof
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GR1002034B (en) Process for the preparation of dry processed particles dry processed particles thus obtained and pharmaceutical compositions containing such particles.
PT84358A (en) Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same
ZA945597B (en) Methyiguanidine derivatives process for their preparation and the compositions containing them
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
DE3377491D1 (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2 analogues, process for the preparation thereof and pharmaceutical compositions containing the same
HU903011D0 (en) Process for the preparation of cyclopeptides and pharmaceutical compositions containing them
PT76870A (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
HUT65768A (en) 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them and process for the production thereof
PT79389B (en) Process for the preparation of 1,2-dithyolane derivates and pharmaceutical compositions containing said derivates
HUT65134A (en) Process for the production of carbapenem-derivatives condensed with cyclohexan-ring and of pharmaceutical compositions containing it
HU901579D0 (en) Process for the preparation of substituted /quinolin-2-yl-methoxy/-phenyl-n'n-sulfonyl-ureas and pharmaceutical compositions containing such compounds

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees